306 related articles for article (PubMed ID: 22465658)
1. A systematic study on lyophilization process of polymersomes for long-term storage using doxorubicin-loaded (PEG)₃-PLA nanopolymersomes.
Ayen WY; Kumar N
Eur J Pharm Sci; 2012 Aug; 46(5):405-14. PubMed ID: 22465658
[TBL] [Abstract][Full Text] [Related]
2. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
Anhorn MG; Mahler HC; Langer K
Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded (PEG)₃-PLA nanopolymersomes: effect of solvents and process parameters on formulation development and in vitro study.
Ayen WY; Garkhal K; Kumar N
Mol Pharm; 2011 Apr; 8(2):466-78. PubMed ID: 21288047
[TBL] [Abstract][Full Text] [Related]
4. A simple method to achieve high doxorubicin loading in biodegradable polymersomes.
Sanson C; Schatz C; Le Meins JF; Soum A; Thévenot J; Garanger E; Lecommandoux S
J Control Release; 2010 Nov; 147(3):428-35. PubMed ID: 20692308
[TBL] [Abstract][Full Text] [Related]
5. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Cheow WS; Ng ML; Kho K; Hadinoto K
Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
[TBL] [Abstract][Full Text] [Related]
6. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
[TBL] [Abstract][Full Text] [Related]
7. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning.
Xu X; Chen X; Ma P; Wang X; Jing X
Eur J Pharm Biopharm; 2008 Sep; 70(1):165-70. PubMed ID: 18472256
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of a nanoparticulate formulation composed of PEG-PLA and PLA as anti-inflammatory agents.
Ishihara T; Takahashi M; Higaki M; Mizushima Y; Mizushima T
Int J Pharm; 2010 Jan; 385(1-2):170-5. PubMed ID: 19837147
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.
Alibolandi M; Sadeghi F; Abnous K; Atyabi F; Ramezani M; Hadizadeh F
Eur J Pharm Biopharm; 2015 Aug; 94():521-31. PubMed ID: 26170161
[TBL] [Abstract][Full Text] [Related]
10. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles.
Howard MD; Lu X; Jay M; Dziubla TD
Drug Dev Ind Pharm; 2012 Oct; 38(10):1270-9. PubMed ID: 22235767
[TBL] [Abstract][Full Text] [Related]
11. Reversibly crosslinked poly(vinyl alcohol) nanoparticles for triggered release of doxorubicin.
Li Y; Wei R; Ji S; Meng F; Zhong Z
J Control Release; 2011 Nov; 152 Suppl 1():e54-5. PubMed ID: 22195923
[No Abstract] [Full Text] [Related]
12. Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations.
Hawe A; Friess W
Eur J Pharm Sci; 2006 Jun; 28(3):224-32. PubMed ID: 16580820
[TBL] [Abstract][Full Text] [Related]
13. Development of highly stabilized curcumin nanoparticles by flash nanoprecipitation and lyophilization.
Chow SF; Wan KY; Cheng KK; Wong KW; Sun CC; Baum L; Chow AH
Eur J Pharm Biopharm; 2015 Aug; 94():436-49. PubMed ID: 26143368
[TBL] [Abstract][Full Text] [Related]
14. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application.
Kasper JC; Schaffert D; Ogris M; Wagner E; Friess W
J Control Release; 2011 May; 151(3):246-55. PubMed ID: 21223985
[TBL] [Abstract][Full Text] [Related]
15. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
Benival DM; Devarajan PV
Int J Pharm; 2012 Feb; 423(2):554-61. PubMed ID: 22155412
[TBL] [Abstract][Full Text] [Related]
16. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
Stevens PJ; Lee RJ
Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
[TBL] [Abstract][Full Text] [Related]
17. Formulation Screening and Freeze-Drying Process Optimization of Ginkgolide B Lyophilized Powder for Injection.
Liu D; Galvanin F; Yu Y
AAPS PharmSciTech; 2018 Feb; 19(2):541-550. PubMed ID: 28849380
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment.
Hecq JD; Lewis AL; Vanbeckbergen D; Athanosopoulos A; Galanti L; Jamart J; Czuczman P; Chung T
J Oncol Pharm Pract; 2013 Mar; 19(1):65-74. PubMed ID: 22801955
[TBL] [Abstract][Full Text] [Related]
19. Elution characteristics of doxorubicin-loaded microspheres differ by drug-loading method and microsphere size.
Kos S; Wasan E; Weir G; Reb P; Cornell C; Ford JA; Liu DM
J Vasc Interv Radiol; 2011 Mar; 22(3):361-8. PubMed ID: 21353988
[TBL] [Abstract][Full Text] [Related]
20. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]